| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.18 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |